In vivo, the inhibition of TRAF6 using mice-specific TRAF6 siRNA inhibit serum anti-collagen II antibodies, MMP-1, MMP-3, and MMP-9, thereby reducing the severity of arthritis and joint inflammation. The gene discussed is TRAF6; the disease is Arthritis.